Stock Analysis
Everjoy Health GroupLtd Full Year 2024 Earnings: CN¥0.16 loss per share (vs CN¥0.054 profit in FY 2023)
Everjoy Health GroupLtd (SZSE:002162) Full Year 2024 Results
Key Financial Results
- Revenue: CN¥1.20b (down 5.8% from FY 2023).
- Net loss: CN¥147.1m (down by 394% from CN¥50.1m profit in FY 2023).
- CN¥0.16 loss per share (down from CN¥0.054 profit in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Everjoy Health GroupLtd shares are up 11% from a week ago.
Risk Analysis
We don't want to rain on the parade too much, but we did also find 1 warning sign for Everjoy Health GroupLtd that you need to be mindful of.
Valuation is complex, but we're here to simplify it.
Discover if Everjoy Health GroupLtd might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SZSE:002162
Everjoy Health GroupLtd
Engages in the research, development, production, and sale of ceramic tiles under Smick brand in China.